Clinical exome sequencing (CES) is increasingly being used as an effective diagnostic tool in the field of pediatric genetics. We sought to evaluate the parental experience, understanding and new GCs, suggesting a need for targeted GC training for genomic testing.
relatively few studies have examined patient and family understanding and experience of the testing. Improved information about the family experience of CES is critical to guide recommendations for best practices.
Studies of traditional genetic testing have showed that the experience and psychological impact is influenced by multiple factors, including the clinical context (disease and type of test results), patient/parent knowledge of genetics, patient-provider relationship, and psychological state of the patient/parent. [7] [8] [9] [10] [11] Genetic results may impact perceived health, healthcare choices, and reproductive decisions. [12] [13] [14] [15] Less is known about these factors in the setting of diagnostic CES. Experiences with CES may differ from those of more traditional genetic testing because of its ability to identify novel or incompletely characterized genetic conditions, the possibility of secondary findings (SFs) unrelated to the diagnosis, the high frequency of uncertain results (novel variants in established, clinically wellcharacterized genes or in novel genes that are not clinically well-characterized) and the potential of reinterpretation of results. [16] [17] [18] [19] [20] Early qualitative evaluation of CES indicates that the parental experience is mixed. Parents express a duty to pursue testing and feelings of worry and relief regardless of their child's results; and acceptance, empowerment, and more focused care when results identify a diagnosis. 21, 22 Parents also report isolation and loss of hope about the future, particularly when the diagnosis is novel or rare, but are accepting of uncertain information. 22, 23 While parents endorse the potential of CES as a diagnostic tool and many want to learn secondary results, some are ambivalent about learning uncertain results. 24, 25 These experiences to some degree are shared by parents of children who have had chromosome microarray analysis (CMA), which also has the possibility of uncertain or incidental results. 15, 26 A more complete understanding of the patient and family experience of CES is important for the development of best clinical practices. Guided by the experiences with research on traditional genetic testing and qualitative studies of CMA, we developed a survey to evaluate the experience and psychological impact of clinical CES on parents of children who had testing at a single institution. The aim of the study was to describe parental understanding of results from CES and expand our understanding of the parental experience, including emotional and social effects, satisfaction with genetic counseling and the decision to have CES for their child. We also examined how parental interpretation of the child's CES results was correlated with these outcomes.
| MATERIALS AND METHODS

| Participants
Participants were English-speaking parents of a consecutive series of symptomatic patients for whom diagnostic CES was performed, 
| Study instrument
A GC and a medical geneticist designed the survey using previously validated measures (Table S1 , Supporting information) and questions developed for this study (Appendix S2). The survey design is described in Appendix S1.
| Statistical analysis
The statistical analysis is described in Appendix S1. Briefly, binary variables were assessed through χ 2 tests and continuous variables
were assessed by analysis of variance (ANOVA). Statistical analysis was completed in SAS. 28 3 | RESULTS
| Enrollment
Three hundred sixty-seven families met the study eligibility criteria. (Table S2 ).
| Demographics
Mothers were the most frequent responders (68% of all responders).
When only 1 parent completed the survey, 83% were mothers. For the analysis presented, fathers' responses were excluded for the 54 families in which both parents completed the survey, to eliminate biases created by correlated data. Seventy-seven percent of the participants reported here are mothers and 91% completed the survey online. Most parents identified as white, non-Hispanic (67%), had a bachelor's degree or higher (71%), and were employed (64%). The mean time from receiving results to completing the survey was 16 months (Table 1) . For the parents who had the option to receive secondary results, most (95%) elected to receive them and 2% (n = 3)
had secondary results. The parents were knowledgeable about genetics: with a mean score of 86% (95% CI: 84%-88%) on the genomic knowledge scale, 30% correctly answered all 8 true/false genetics questions and over half (58%) correctly answered the questions specific to CES.
The mean age of the child who had CES was 6.8 years at the time of testing. A quarter was seen as inpatient consults. The majority (64%) of the children had a neurological component to their illness such as development delay, intellectual disability, or seizures. Fewer (20%) had involvement of more than 1 system but no neurological component (eg, a kidney and heart defect) or an isolated condition (eg, a heart defect; Table 1 ).
| Parental recall of testing process
When making the decision to have CES for their child, parents indicated that they received advice from a variety of specialists and used other resources, the most frequent being educational websites (53%).
Most parents (65%) reported discussing CES with the provider for an hour or less before making the decision to have CES. Over half (61%)
reported that their child had prior genetic testing (Table S3 ). Table 2 ).
| Interpretation of child's CES results
Overall, the parental interpretation of the child's result agreed with the clinician interpretation in 79% of cases. The frequency of parental concordance was somewhat greater for results interpreted by the clinician as positive (89%) than for those interpreted as negative (72%) or uncertain (71%) (P = .02, Table S4A ). Parents not infrequently interpreted negative results as uncertain (17%) or uncertain results as negative (14%) ( Table 2 ). In 73% of the instances where the parental interpretation disagreed with the clinician, the clinician had reinterpreted the laboratory report. For most of these differences in interpretation, the parent's interpretation was either consistent with the laboratory report or the child had multiple variants reported. Parents whose interpretation agreed with the clinician's interpretation reported more positive experiences from the testing and had more healthy behaviors and lower health locus of control. Time from results disclosure to survey completion was not associated with correct parental interpretation (Table S4A ,B).
| Parental experience of CES
The most common emotions parents reported at the time of learning their child's CES results were frustration (33%), worry (30%), and curi- In the analysis restricted to the 147 parents whose child was evaluated in clinic and therefore had a pre-test GC session, the majority of parents (65%) reported being satisfied with the genetic counseling experience, as measured by the genetic counseling satisfaction scale (GCSS), and this did not differ by the parental interpretation of the child's results. The proportion of parents reporting satisfaction was somewhat greater when the GC had ≥5 years of experience (76%) than when the GC had less experience (58%) (P = .02). Parental depression and anxiety and time from results disclosure to survey completion were not associated with genetic counseling satisfaction (Table S5A ). Parents satisfied with genetic counseling reported more personal healthy behaviors (P = .005) than parents who had some dissatisfaction (Table S5B ).
| Parental opinions about timing and decision to have CES
Twenty-one percent of parents expressed some regret over the decision to have CES for their child; regret was similar across result types (Table S6A ). There was a modest increase in reported regret when their GC had fewer than 5 years of experience than when the GC had greater experience (32% vs 16%, P = .02). Parental depression was modestly associated (P = .02) with regret, while anxiety and the time from results disclosure to survey completion were not. The number of reported positive experiences related to CES was greater for parents without regret (P = .002, Table S6B ). Genetic counseling satisfaction and regret were moderately associated; the proportion with regret was 32% among parents who were dissatisfied with the genetic counseling process, but only 17% among those who were satisfied (P = .01).
When asked whether they would have changed the timing of when they learned the CES results, over half (51%) of parents indicated they would have had testing sooner if it were possible (Figure 2 
| Associations of parental psychological experience
Thirteen percent of parents had a generalized anxiety disorder-7
(GAD-7) score ≥10, indicating moderate to severe anxiety, which is similar to the general population prevalence of 18.1%. 29 Twelve percent of parents had a personalized health questionnaire-9 (PHQ-9) score ≥10 indicating moderate or severe depression, which is higher than the prevalence of the general population (7.6%), but more similar to the prevalence in women (9.5%). 30 Parental depression and anxiety
were not associated with time from results disclosure. The presence of depression and anxiety were greater in parents who interpreted their children's results as positive (14% and 15%, respectively) than negative (8% and 8%, respectively) or uncertain (4% and 7%, respectively), but the differences were not significant (P = .25 and P = .22, respectively). The adapted multidimensional impact of cancer risk assessment (aMICRA) score was used to assess impact, including distress, uncertainty and positivity (reverse scored) of the genetic test results on the parents. On average, the aMICRA was 12 points higher (more negative impact) in parents who interpreted the results as positive compared to those who interpreted results as negative, after adjusting for confounders (P < .0001, Figure 3 , Table 3 ). The same pattern was observed for the aMICRA distress and uncertainty subdomains but not the positivity subdomain (Table S7A-C) . Parents who were not anxious or depressed, or who had more healthy behaviors, had significantly lower overall aMICRA scores and lower scores in the uncertainty and distress subdomains. The time from results disclosure to completion of the study survey was not associated with the aMICRA scores ( Table 3) . a Adjusted for confounders of child gender and method of result disclosure, other significant variables were not associated with parental interpretation of results (primary predictor).
| DISCUSSION
b Analysis excludes inpatients.
| Timing of testing
Over half (61%) of the parents recalled that their child had other genetic testing prior to undergoing CES, and for many of these families, CES was the next step in their child's diagnostic odyssey. While the average age of 6.8 years at the time of testing was relatively young, older child age was associated with a lower positive impact of the results, as measured by the aMICRA positivity domain. Additionally, many parents wanted to learn of their child's results sooner, for example, at the time of the child's symptom onset, or to learn of the risk before they had children, even when this was not realistic (such as in de novo conditions). These results suggest, that at least for some parents, an aggressive approach to genetic diagnosis, potentially with CES as a first-tier option, even in the prenatal or neonatal periods, should be offered. Further research into the most effective timing for CES to maximize medical and familial benefits is needed.
| Experience
Similar to studies on reactions to CMA and CES testing that have reported parental feelings of relief, better ability to cope with guilt, but also worry and a loss of hope for the future, [22] [23] [24] 26 experience caring for a sick child increases their capacity to manage additional negative health information. 24 This resilience may be reflected in our observation of lower aMICRA scores and higher satisfaction with genetic counseling in parents who reported more personal healthy behaviors.
An ongoing challenge of genetic testing is evaluating medical utility. 32 There are still relatively few genetic diagnoses with effective treatments or cures. Despite this, over one-third of parents in our study reported some perceived medical or non-medical utility, and this was more frequent when the parental interpretation of results was positive. Our findings are consistent with other studies that have documented patients' perceived utilities of genetic testing for providing closure, focusing clinical care, guiding reproductive decisions, and increasing access to research and social supports. 22, 23, 33 
| Limitations
There are limits to the generalizability of our findings given the participation rate of 57%, with an overrepresentation of white, nonHispanic participants. Several parents chose not to respond because they found the questions brought up difficult thoughts or they were concerned about privacy, and their experiences may have differed.
Only the mothers' responses were included in the analysis when both parents responded, however, when the analysis was repeated with the excluded fathers' responses, results were similar. (Paired parental experiences will be reported separately.) The study was available only in English and respondents had high levels of employment and education. Additionally, most parents had prior experience with genetic and other medical testing and high knowledge of genetics. Our study sample came from a single institution, but 5 geneticists and 10 GCs were involved in care. Although counseling and disclosure sessions were not formally standardized, our division uses peer training and promotes client-centered counseling, which foster similarities across providers' practices. Additionally, the sample included both outpatients and patients evaluated during hospitalization. While we did not observe associations with these variables, variation in medical acuity may have affected patient experiences in ways not measured by this study. Our study was retrospective and therefore expectations before testing and baseline psychological state could not be assessed. The measures of aMICRA, GCSS and DRS were validated in adult patients who themselves were tested; validity in our study of parents responding to the testing of their children is unknown. However, the pattern of aMICRA scores stratified by type of result is consistent with results in published studies of adult patients. 11, 13 Because this was an exploratory analysis, we did not correct for multiple testing and some observed associations may have occurred by chance.
| Practice implications
Our results highlight some of the challenges of CES, including the complexity of nuanced results disclosures and managing expectations. 35 Introducing the potential for difference in laboratory and cli- Given the parallels of WGS and CES, our results should also be considered by clinicians offering WGS.
